Famar Appoints Ian Muir as Chief Executive Officer
05/12/2017

Laboratoire FAMAR-FFH

71-73, avenue des Champs-Elysées

75008 Paris

Press Release

 

 Famar Appoints Ian Muir as Chief Executive Officer

 

Paris, 14 November 2017 – Famar, one of Europe’s leading providers of contract manufacturing and development services to the pharmaceutical and health & beauty industries, has today announced that Ian Muir has been appointed CEO of the group, effective from 20 November.

Mr Muir has over 25 years’ experience in the global pharmaceutical industry, most recently as Managing Director of Aesica Pharmaceuticals and Global President at Catalent Pharma. Prior to that, he held senior roles at Cardinal Health EU and Swindon Site. 

John Davison, Chairman of Famar, said: “We are delighted to welcome Ian to Famar. This is an important step forward in the company’s turnaround and he will lead the development of the new business plan as we continue to focus on regaining customer trust. Ian has a strong track record of delivering growth and he has deep technical knowledge in a number of important areas including commercial leadership and licensing, operations, and product development. His leadership will also bring stability and significant industry expertise to the senior team which now has unparalleled industry experience.”

Ian will be supported by Friedrich Sernetz and Markus Hölzl, who have been sharing the position of interim CEO since August and will resume their roles as CFO and CCO, respectively. Markus has over 30 years' experience, most recently as Group Chief Financial Officer of Klockner Pentaplast group whilst Friedrich has 20 years of pharmaceutical industry experience, having joined Famar last year from Aenova, where he was Chief Commercial Officer.

Ian Muir, Incoming CEO of Famar commented: “I am excited to be joining Famar and look forward to leading the company as we continue the turnaround. There is lots of work still to do, but things are clearly moving in the right direction. The company is backed by supportive shareholders and I will be able to rely on a talented and experienced team around me”.    

About Famar 

Famar is a leading provider of Contract Manufacturing and Development Services to the Pharmaceutical and Health & Beauty industry. From development to production and distribution, Famar’ services enable the Health and Personal Care industry to deliver innovative and accessible solutions for the improvement of patients & consumers’ lives. We supply a wide range of more than 1800 products to a broad customer base in 125 international markets. With 11 production sites in Europe (four in France, four in Greece, and single sites in Italy, Spain and the Netherlands) and one in North America, Famar has one of the largest European footprint’s in the sector.

Media contacts

 Olivier Blain

Adding Value Conseils

Ob@addingvalueconseils.com

+33 6 72 28 29 20

 

Michael Turner or Andrew Hughes

Finsbury

Michael.turner@finsbury.com / Andrew.Hughes@finsbury.com

+44 207 2513801

 

Catherine Kuttner

Famar

c.kuttner@famar.eu

+33 6 08 70 39 12